Directory
>
Anita Mathias
Anita Mathias
Vice President, Clinical Pharmacology & Development | Gossamer Bio
United States
Anita Mathias
Summary
Anita Mathias is a seasoned pharmaceutical executive with over 20 years of experience in clinical pharmacology and drug development. She has successfully led teams through the intricate processes of clinical trials and regulatory approvals for several market-leading products, including treatments for HIV and Hepatitis C. As Vice President at Gossamer Bio and an Affiliate Professor at the University of Washington, she merges academic insight with industry expertise. Anita's leadership has been pivotal in navigating complex global regulatory landscapes, having represented clinical pharmacology at multiple FDA Advisory Committees. Her academic background in pharmacokinetics complements her extensive practical experience, making her a valuable asset in the pharmaceutical sector. Anita is also recognized as a Fellow of the American Institute for Medical and Biological Engineering, highlighting her contributions to the field. She is passionate about fostering innovation in drug development and mentoring the next generation of scientists.
Anita Mathias
Work Experience
Vice President, Clinical Pharmacology & Development at
Gossamer Bio
September 2020 - Present
Affiliate Professor of Pharmaceutics at
University of Washington, LLC
August 2020 - Present
Executive Director at
Gilead Sciences Austria
November 2018 - August 2020
Sr Director - Clinical & Quantitative Pharmacology at
Gilead Sciences Austria
January 2016 - November 2018
Director Clinical Pharmacology at
Gilead Sciences Austria
January 2014 - January 2016
Associate Director of Clinical Pharmacology at
Gilead Sciences Austria
June 2011 - January 2014
Clinical Research Scientist at
Gilead Sciences Austria
June 2004 - June 2011
Anita Mathias
Education
Frequently Asked Questions about Anita Mathias
What is Anita Mathias email address?
Anita Mathias's primary email address is ********@u.washington.edu. To view the full verified email and additional contact details, sign up for free with Muraena.
What company does Anita Mathias work for?
Anita Mathias is a Vice President, Clinical Pharmacology & Development at Gossamer Bio, a company specializing in Commercial physical research.
Where Anita Mathias graduated from?
Anita Mathias holds a degree in Pharmacokinetics from University of Washington.
How can I directly contact Anita Mathias?
To contact Anita Mathias directly, you can use the email address ********@u.washington.edu. Complete contact information is available upon registration with Muraena.
Who is Anita Mathias?
Anita Mathias is a seasoned pharmaceutical executive with over 20 years of experience in clinical pharmacology and drug development. She has successfully led teams through the intricate processes of clinical trials and regulatory approvals for several market-leading products, including treatments for HIV and Hepatitis C. As Vice President at Gossamer Bio and an Affiliate Professor at the University of Washington, she merges academic insight with industry expertise. Anita's leadership has been pivotal in navigating complex global regulatory landscapes, having represented clinical pharmacology at multiple FDA Advisory Committees. Her academic background in pharmacokinetics complements her extensive practical experience, making her a valuable asset in the pharmaceutical sector. Anita is also recognized as a Fellow of the American Institute for Medical and Biological Engineering, highlighting her contributions to the field. She is passionate about fostering innovation in drug development and mentoring the next generation of scientists.
Anita`s contact details
********@u.washington.edu
*****@uw.edu
********@gossamerbio.com
*************@gilead.com
Colleagues
Executive Director
Executive Director, Data Management
VP Medical Affairs
Scientific Advisory Board Member
Vice President Clinical Operations
VP, Program Team Lead
Executive Director, Human Resources & Head of Talent Acquisition
Executive Director Data Management
VP, CMC
Vice President, Clinical Development